R. Landewé

6.8k citations

50 papers · 3.5k indexed · 3 hit papers · h-index 21

Impact in

Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 38
- Spondyloarthritis Studies and Treatments 34
- Rheumatoid Arthritis Research and Therapies 26
Orthopedics and Sports Medicine 9
- Bone and Joint Diseases 6

Co-authors: Désirée van der Heijde Joachim Sieper Philip J. Mease Joseph M. Braun Iain B. McInnes Hanno B. Richards Bruce Kirkham Shephard Mpofu
Journals: Annals of the Rheumatic Diseases (22 papers)Lara D. Veeken (9 papers)The Journal of Rheumatology (3 papers)Arthritis Care & Research (2 papers)The Lancet (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

R. Landewé

47 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis 2015 · 572 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 New England Journal of Medicine
2015 The Lancet
2008 Annals of the Rheumatic Diseases

Peers

Countries citing papers authored by R. Landewé

Since Specialization

Citations

This map shows the geographic impact of R. Landewé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Landewé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Landewé more than expected).

Fields of papers citing papers by R. Landewé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Landewé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Landewé. The network helps show where R. Landewé may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Landewé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Landewé Line = papers co-authored together R. Landewé links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritis Annals of the Rheumatic Diseases ·Désirée van der Heijde, Victoria Navarro‐Compán, R. Landewé, Joachim Sieper, F. van Gaalen, Lianne S. Gensler, Pedro Machado, Helena Marzo‐Ortega, Denis Poddubnyy, Mikhail Protopopov, Sofía Ramiro, Alexandre Sepriano, Xenofon Baraliakos	2025	0
2	Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study The Lancet ·R. Landewé, Joachim Sieper, Philip J. Mease, Robert D. Inman, R. Lambert, Atul Deodhar, Helena Marzo‐Ortega, Marina Magrey, Uta Kiltz, Xin Wang, Li Mei, Sheng Zhong, Nael M. Mostafa, Apinya Lertratanakul, Aileen L. Pangan, J. Anderson	2018	70
3	FACTORS ASSOCIATED WITH THE RHEUMATOLOGIST DECISION TO ORDER MAGNETIC RESONANCE IMAGING (SI-MRI) OF THE SACROLILIAC JOINTS AND/OR HLA-B27 TESTING IN PATIENTS WITH SPONDYLOARTHRITIS IN CLINICAL PRACTICE JCR Journal of Clinical Rheumatology ·Wilson Bautista‐Molano, R. Landewé, Carlos De La Serna, Rafael Valle‐Oñate, Désirée van der Heijde	2016	3
4	Is Treat-To-Target Really Working? A Longitudinal Analysis in BIODAM The Journal of Rheumatology ·Walter P. Maksymowych, Maggie Larché, C. J. R. Thorne, Gilles Boire, Joanne Homik, Cheryl Barnabé, Prinon Rahman, Carol Hitchon, D. van der Heijde, R. Landewé, Edna Hutchings, R. Dadashova, Joel Paschke, Sofía Ramiro	2016	1
5	Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative Annals of the Rheumatic Diseases ·Laure Gossec, Agnès Portier, R. Landewé, Adrien Etcheto, Victoria Navarro‐Compán, Féline P B Kroon, Désirée van der Heijde, Maxime Dougados	2016	38
6	Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD Lara D. Veeken ·Polina Putrik, Sofía Ramiro, Elisabeth Lie, András Keszei, Tore K Kvien, Désirée van der Heijde, R. Landewé, Till Uhlig, Annelies Boonen	2016	27
7	Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis New England Journal of Medicine ·Philip J. Mease, Iain B. McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, R. Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan, Hanno B. Richards, Shephard Mpofu Hit paper breakdown →	2015	572
8	Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet ·Iain B. McInnes, Philip J. Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T. Ritchlin, Proton Rahman, Désirée van der Heijde, R. Landewé, Philip G. Conaghan, Alice B. Gottlieb, Hanno B. Richards, Luminita Pricop, Gregory Ligozio, Manmath Patekar, Shephard Mpofu Hit paper breakdown →	2015	650
9	Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis The Journal of Rheumatology ·Walter P. Maksymowych, R. Landewé, Martín Rudwaleit, D. van der Heijde, Maxime Dougados, Philip J. Mease, John D. Reveille, Jessica A. Walsh, A. Kivitz, J. Braun, Atul Deodhar, C. Stach, Bengt Hoepken, Pritam Singh, J. Sieper	2014	3
10	A PHYSICALLY DEMANDING JOB MAY AMPLIFY THE EFFECT OF DISEASE ACTIVITY ON THE DEVELOPMENT OF SYNDESMOPHYTES IN PATIENTS WITH AS Annals of the Rheumatic Diseases ·Sofía Ramiro, Astrid van Tubergen, R. Landewé, Annelies Boonen, C. Stolwijk, Maxime Dougados, Filip Van den Bosch, D. van der Heijde	2014	1
11	Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results of the Rapid-axSpA Study Value in Health ·J. Sieper, A. Kivitz, Astrid van Tubergen, Atul Deodhar, G. Coteur, Pritibha Singh, R. Landewé	2013	2
12	EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS Lara D. Veeken ·P. Emery, Dominique Baeten, Joachim Sieper, J. Braun, Désirée van der Heijde, Iain B. McInnes, Jacob M. van Laar, R. Landewé, B P Wordsworth, J. Wollenhaupt, H Kellner, I. Paramarta, A. Bertolino, A. Wright, Wolfgang Hueber	2012	6
13	Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction? Lara D. Veeken ·Astrid van Tubergen, D. van der Heijde, M. Dougados, Herman Mielants, R. Landewé	2012	10
14	DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH EARLY RA TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT METHOTREXATE ALONE: CASE FOR ANTI-TNF CARTILAGE PROTECTION Lara D. Veeken ·R. Landewé, Edward Keystone, Smolen Js, Mary B. Goldring, B. Guérette, Kartick Patra, M. Cifaldi, van der Heijde	2011	2
15	JOINT SPACE NARROWING HAS A STRONGER IMPACT ON PHYSICAL FUNCTION THAN JOINT EROSION: RESULTS FROM EIGHT YEAR LONGITUDINAL ANALYSES Lara D. Veeken ·van der Heijde, R. Landewé, B. Guerette, Sarbani Roy, Karali Patra, E. Keystone	2011	5
16	2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis Annals of the Rheumatic Diseases ·Désirée van der Heijde, Joachim Sieper, Walter P. Maksymowych, Maxime Dougados, Rubén Burgos‐Vargas, R. Landewé, Martín Rudwaleit, Jürgen Braun	2011	308
17	ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Annals of the Rheumatic Diseases ·Désirée van der Heijde, E. Lie, Tore K Kvien, Joachim Sieper, Filip Van den Bosch, Joachim Listing, Joseph M. Braun, R. Landewé Hit paper breakdown →	2008	455
18	Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis Lara D. Veeken ·Debby Vosse, C. Heijckmann, R. Landewé, Désirée van der Heijde, S. van der Linden, Piet Geusens	2007	22
19	Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries Annals of the Rheumatic Diseases ·Annelies Boonen, D. van der Heijde, R. Landewé, François Guillemin, Maureen Rutten‐van Mölken, Maxime Dougados, Herman Mielants, Kurt De Vlam, Hille van der Tempel, Sophie Amalie H. Boesen, Anneke Spoorenberg, Harry C. Schouten, Sj. van der Linden	2003	92
20	Combined spa–exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial Arthritis & Rheumatism ·Astrid van Tubergen, R. Landewé, Désirée van der Heijde, Alita Hidding, Nico Wolter, Max Asscher, A. Falkenbach, E. Genth, Henk Goei Thè, Sjef van der Linden	2001	217

About R. Landewé

R. Landewé is a scholar working on Rheumatology, Orthopedics and Sports Medicine, Immunology, Hematology and Family Practice, having authored 50 papers that have together received 3.5k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (34 papers), Rheumatoid Arthritis Research and Therapies (26 papers), Psoriasis: Treatment and Pathogenesis (17 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Bone and Joint Diseases (6 papers), Spine and Intervertebral Disc Pathology (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Systemic Sclerosis and Related Diseases (2 papers). The work is most often cited by research in Rheumatology (2.7k citations), Hematology (1.1k citations), Immunology (1.9k citations), Complementary and Manual Therapy (166 citations) and Family Practice (77 citations). R. Landewé has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Désirée van der Heijde, Joachim Sieper, Philip J. Mease, Joseph M. Braun, Iain B. McInnes, Hanno B. Richards, Bruce Kirkham, Shephard Mpofu, Proton Rahman and Luminita Pricop. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Rheumatology, Arthritis Care & Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact